![]() | Up a level |
Gratzke, Christian; Maanen, Rob van; Chapple, Christopher; Abrams, Paul; Herschorn, Sender; Robinson, Dudley; Ridder, Arwin; Stoelzel, Matthias; Paireddy, Asha; Yoon, Sang Jin; Al-Shukri, Salman; Rechberger, Tomasz; Müller, Elizabeth R. (2018): Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II). In: European Urology, Vol. 74, No. 4: pp. 501-509
White, William B.; Chapple, Christopher; Gratzke, Christian; Herschorn, Sender; Robinson, Dudley; Frankel, Jeffrey; Ridder, Arwin; Stoelzel, Matthias; Paireddy, Asha; Maanen, Robert van; Weber, Michael A. (2018): Cardiovascular Safety of the (3)-Adrenoceptor Agonist Mirabegron and the Antimuscarinic Agent Solifenacin in the SYNERGY Trial. In: Journal of Clinical Pharmacology, Vol. 58, No. 8: pp. 1084-1091
Weber, Michael A.; Chapple, Christopher R.; Gratzke, Christian; Herschorn, Sender; Robinson, Dudley; Frankel, Jeffrey M.; Ridder, Arwin M.; Stoelzel, Matthias; Paireddy, Asha; Maanen, Robert van; White, William B. (2018): A strategy utilizing ambulatory monitoring and home and clinic blood pressure measurements to optimize the safety evaluation of noncardiovascular drugs with potential for hemodynamic effects: a report from the SYNERGY trial. In: Blood Pressure Monitoring, Vol. 23, No. 3: pp. 153-163